Name:
Tumor Microenvironment and Resistance to Therapies Lab
Leader:
- Andreï TURTOI
Research axis :
Biomarker discovery, cancer-stroma interactions, mAb development for targeted therapies, primary and secondary liver cancers;
Expertise / know-how:
Proteomics for biomarker discovery, in vivo models (PDX, CAM, etc.), experimental histology (human and mouse) & imaging (IHC, Fluorescence & MALDI-MS);
Location:
IRCM, Montpellier